Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2008
11/05/2008CN101300267A Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof in particular for therapeutic purposes
11/05/2008CN101300031A Use of SDF-1 for the treatment and/or prevention of neurological diseases
11/05/2008CN101300020A Dieting composition comprising plant-derived essential oil as active ingredient, sheet-type dieting composition comprising the composition, transdermal pharmaceutical preparation for dieting, and meth
11/05/2008CN101300011A Formulations comprising jorumycin-, reni eramycin-, safracin- or saframycin-related compounds for treating proliferative diseases
11/05/2008CN101300010A Pharmaceutical preparation having excellent photostability
11/05/2008CN101299998A Method for encapsulating therapeutic substances in cells
11/05/2008CN101299994A Use of a copolymer in the form of a solubiliser for a poorly water-soluble compound
11/05/2008CN101299993A Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
11/05/2008CN101298501A High polymer nano-particle containing carboxyl, preparation and use thereof
11/05/2008CN101297978A Preparation method of hydroxyapatite nano pole
11/05/2008CN101297977A Biological adhesive agent and use thereof
11/05/2008CN101297974A Pegylated glycosides of aerial parts of epimedium, and preparation and use thereof
11/05/2008CN101297973A Highly bioadhesive and thermosensitive hydrogel, and preparation method and application thereof
11/05/2008CN101297972A Special glue for producing algal polysaccharides plant capsules
11/05/2008CN101297971A Injection containing oil medicine and preparation thereof
11/05/2008CN101297970A Antimetabolites and potentiating agent thereof carried by anticancer sustained-release injection
11/05/2008CN101297968A Preparation of pig serum immunoglobulin microsphere novel dosage form
11/05/2008CN101297964A Preparation of chicken thymosin microsphere novel dosage form
11/05/2008CN101297962A Preparation of pig interferon novel dosage form
11/05/2008CN101297961A Preparation of dog interferon novel dosage form
11/05/2008CN101297960A Preparation of chicken interferon novel dosage form
11/05/2008CN101297959A Preparation of chicken interleukin-2 microsphere novel dosage form
11/05/2008CN101297958A Medicament composition for preventing and treating colibacillosis of chicken
11/05/2008CN101297941A Combined Chinese and western medicine sustained-release agent for preventing and treating rabbit coccidiosis and preparation method thereof
11/05/2008CN101297900A Medicine new purpose of Ampelopsis Sinica stem leaf total flavones and single component myricetin
11/05/2008CN101297877A Preparation of white peony root total glycosides granules
11/05/2008CN101297875A Preparation of white peony root total glycosides capsules
11/05/2008CN101297869A Gastralgia dispersed tablet and preparation
11/05/2008CN101297826A Compound Bupleurum injection for curing common cold of dog and preparation thereof
11/05/2008CN101297824A Preparation of sustained-release medical membrane
11/05/2008CN101297823A Medicament for preventing and treating Alzheimerí»s disease
11/05/2008CN101297820A Streptococcus faecium function signal molecule formulation and product thereof for reducing fat and slimming
11/05/2008CN101297817A Combination for promoting carapace growth and recovery of shrimp and crab of crustacean
11/05/2008CN101297814A Emulsifiable paste for curing acne and preparation thereof
11/05/2008CN101297795A Compound florfenicol powder for animals and preparation thereof
11/05/2008CN101297790A Zaltoprofen sustained-release preparation and preparation thereof
11/05/2008CN100430433C Poly propenoic acid/polypeptide grafted copolymer and its preparing method and use
11/05/2008CN100430093C Temperature responsive delivery systems
11/05/2008CN100430092C Lipid composition for providing genes and polypeptides with medicines by mucosa and its preparation
11/05/2008CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
11/05/2008CN100430044C Nail restructuring compositions for topical application
11/04/2008US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility
11/04/2008US7446099 Compositions and methods for biodegradable polymer-peptide mediated transfection
11/04/2008US7446093 Administering cyclosporin and dimethyl sulfoxide sterile injectable solution by injection into a cerebrospinal fluid or cerebrospinal fluid spaces
11/04/2008US7446090 FSH formulation
11/04/2008US7445802 Conjugates of alliinase with a protein carrier that targets the alliinase to specific cells are used in combination with alliin to produce allicin at a desired target site to kill cancer cells or pathogens.
11/04/2008US7445768 Delivery of sedative-hypnotics through an inhalation route
11/04/2008US7445764 Carrier-drug conjugate
11/04/2008CA2578881C Vitamin d compositions and method of administration to a human being
11/04/2008CA2473760C Topical ivermectin composition
11/04/2008CA2441860C Systems for delivering a cosmetic and/or therapeutic active to oral surfaces
11/04/2008CA2362481C Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/04/2008CA2330186C Divalent antibody fragments
11/04/2008CA2324260C Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations
11/04/2008CA2282893C Heat stable antacid and antigas suspensions
11/04/2008CA2197432C Liquid immunoglobulin formulations
11/04/2008CA2169834C Pharmaceutical formulations of nerve growth factor
10/2008
10/30/2008WO2008131419A2 Glycoconjugates of rna interference agents
10/30/2008WO2008130382A2 Fusion proteins comprising an anti -inflammatory cytokine and an antigen for treatment of immune disorders
10/30/2008WO2008130211A1 Dynamic, stechiometric solution for support and induced equilibrium
10/30/2008WO2008129980A1 Particulate composition comprising reduced coenzyme q10, and method for production thereof
10/30/2008WO2008129973A1 Hollow fiber-shaped organic nanotube having low-molecular organic compound intercalated therein and method of producing the same
10/30/2008WO2008129937A1 Multilayer structure for oral applications and method for production thereof
10/30/2008WO2008129846A1 Pharmaceutical composition
10/30/2008WO2008129153A1 Oil-in-oil emulsion-type pharmaceutical composition
10/30/2008WO2008129106A2 Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof
10/30/2008WO2008129020A1 Vaccination regimen for b-cell vaccines
10/30/2008WO2008128779A1 Ophthalmic oil-in-water emulsions containing prostaglandins
10/30/2008WO2008128717A1 Improved three-dimensional biocompatible skeleton structure containing nanoparticles
10/30/2008WO2008128342A1 Composition for enhancing bone formation
10/30/2008WO2008128330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008WO2008128329A1 Endotoxin removal
10/30/2008WO2008084237A3 Stabilization of aqueous compositions of proteins with displacement buffers
10/30/2008WO2008052126A3 Ointment comprising phosphatidylserine as active agent for cancer treatment
10/30/2008WO2007149500A3 Formulations containing hybrid dendrimers
10/30/2008WO2007142683A3 Self-assembling monomers and oligomers as surface-modifying endgroups for polymers
10/30/2008WO2007139959A3 Bruise amelioration composition and method of use
10/30/2008WO2007126732A3 Ruminant feed composition and method of making
10/30/2008WO2007098205A3 Cocoa products and methods of treating cardiovascular conditions with sugar-free cocoa
10/30/2008WO2004112717A3 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
10/30/2008US20080269466 Modified Antibody Fragments
10/30/2008US20080269465 Tumor necrosis factor specific immunoglobulin for use in prevention and treatment of rheumatoid arthritis, ulcerative colitis, multiple sclerosis and crohn's disease
10/30/2008US20080269355 Novel Solubility Enhancer and Use Thereof
10/30/2008US20080269354 Dipentaerythritol C3-24ester, particulate phase comprises particles of polymethyl methacrylate; skin care
10/30/2008US20080269353 Preventative Composition For Ophthalmic Use
10/30/2008US20080269308 Allantoin-containing skin cream
10/30/2008US20080269198 Oral administering; drug with carrier and excipient
10/30/2008US20080269187 Applying propylene glycol to ear with antibiotic, viricides, fungicide, antiinflammatory agents
10/30/2008US20080269181 Methods for treating a posterior segment of an eye
10/30/2008US20080269178 Antiinflammatory agents; heating glucocorticoid with water and surfactant
10/30/2008US20080269175 Silicone permeated with therapeutic agents; butyl acetate solvent; minocycline, rifampin, clonidine, sulindac; drug-loaded polymeric boots, sheaths, discs; elute drug more rapidly
10/30/2008US20080269166 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
10/30/2008US20080269134 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080269119 Ophthalmic Device and Related Methods and Compositions
10/30/2008US20080269112 Antineoplastic Agents Targeted via Glut Transporters
10/30/2008US20080269111 Administering to a subject an apolipoprotein-sphingomyelin complex comprising an apolipoprotein and the lipid sphingomyelin in an amount effective to achieve a serum level of free or complexed apolipoprotein in the range of 30 mg/dL to 300 mg/dL after administration; treatment of cardiovascular disease
1 ... 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 ... 1712